{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:25:01Z","timestamp":1794435901647,"version":"4.9.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K16912"],"award-info":[{"award-number":["JP22K16912"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The m.3243\u2009A\u2009&gt;\u2009G mitochondrial DNA variant is a major pathogenic variant associated with various clinical phenotypes, including hearing impairment and diabetes. This study retrospectively analyzed clinical data from 37 patients with the m.3243\u2009A\u2009&gt;\u2009G variant to clarify the relationship between clinical characteristics and hearing loss. Most patients developed post-lingual, late-onset sensorineural hearing loss (SNHL), with flat-type audiometric configurations being the most common. Blood heteroplasmy levels were negatively correlated with age at genetic testing (R\u00b2 = 0.6303), and age-adjusted heteroplasmy levels were inversely associated with age at onset of hearing loss (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.029). A significant difference in clinical characteristics was observed between patients with hearing loss and\/or diabetes alone and those with multiple organ involvement, with the latter group showing a lower BMI (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.031) and more severe hearing loss (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Two cases initially presenting with maternally inherited deafness and diabetes progressed to MELAS (mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes), demonstrating the importance of early systemic evaluation. Cochlear implantation was considered for advanced hearing loss, although systemic complications were a challenge. Our findings suggest that hearing loss may be an early risk factor of systemic mitochondrial disease, particularly in lean individuals. Comprehensive assessment, including BMI and genetic testing, may aid in the early diagnosis and management of patients with m.3243\u2009A\u2009&gt;\u2009G variant.\n                  <\/jats:p>","DOI":"10.1038\/s10038-025-01412-3","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T03:04:32Z","timestamp":1761188672000},"page":"145-149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical characteristics and hearing impairment in carriers of the m.3243\u2009A\u2009&gt;\u2009G variant"],"prefix":"10.1038","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6620-4546","authenticated-orcid":false,"given":"Natsumi","family":"Uehara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6457-6231","authenticated-orcid":false,"given":"Takeshi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikari","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Katsunuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Kakigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Nibu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"1412_CR1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s00415-013-7225-3","volume":"261","author":"M Mancuso","year":"2014","unstructured":"Mancuso M, Orsucci D, Angelini C, Bertini E, Carelli V, Comi GP, et al. The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender?. J Neurol. 2014;261:504\u201310.","journal-title":"J Neurol"},{"key":"1412_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ymgme.2019.09.003","volume":"128","author":"RM Boggan","year":"2019","unstructured":"Boggan RM, Lim A, Taylor RW, McFarland R, Pickett SJ. Resolving complexity in mitochondrial disease: Towards precision medicine. Mol Genet Metab. 2019;128:19\u201329.","journal-title":"Mol Genet Metab"},{"key":"1412_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s10038-021-00990-2","volume":"67","author":"N Uehara","year":"2022","unstructured":"Uehara N, Fujita T, Yamashita D, Yokoi J, Katsunuma S, Kakigi A, et al. Genetic background in late-onset sensorineural hearing loss patients. J Hum Genet. 2022;67:223\u201330.","journal-title":"J Hum Genet"},{"key":"1412_CR4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/ajmg.a.32703","volume":"149A","author":"M Mehrazin","year":"2009","unstructured":"Mehrazin M, Shanske S, Kaufmann P, Wei Y, Coku J, Engelstad K, et al. Longitudinal changes of mtDNA A3243G mutation load and level of functioning in MELAS. Am J Med Genet A. 2009;149A:584\u20137.","journal-title":"Am J Med Genet A"},{"key":"1412_CR5","doi-asserted-by":"crossref","unstructured":"Grady JP, Pickett SJ, Ng YS, Alston CL, Blakely EL, Hardy SA, et al. mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease. EMBO Mol Med. 2018;10:e8262.","DOI":"10.15252\/emmm.201708262"},{"key":"1412_CR6","unstructured":"Mazzoli M, Camp GV, Newton V, Giarbini N, Declau F, Parving A. Vol. \uff11,148\u201350 (Audiological Medicine 2009)."},{"key":"1412_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/jmg.37.1.38","volume":"37","author":"S Usami","year":"2000","unstructured":"Usami S, Abe S, Akita J, Namba A, Shinkawa H, Ishii M, et al. Prevalence of mitochondrial gene mutations among hearing impaired patients. J Med Genet. 2000;37:38\u201340.","journal-title":"J Med Genet"},{"key":"1412_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41439-020-00115-9","volume":"7","author":"Y Maeda","year":"2020","unstructured":"Maeda Y, Sasaki A, Kasai S, Goto S, Nishio SY, Sawada K, et al. Prevalence of the mitochondrial 1555 A>G and 1494 C>T mutations in a community-dwelling population in Japan. Hum Genome Var. 2020;7:27.","journal-title":"Hum Genome Var"},{"key":"1412_CR9","first-page":"203","volume":"56","author":"S Usami","year":"2000","unstructured":"Usami S, Abe S, Akita J, Shinkawa H, Kimberling WJ. Sensorineural hearing loss associated with the mitochondrial mutations. Adv Otorhinolaryngol. 2000;56:203\u201311.","journal-title":"Adv Otorhinolaryngol"},{"key":"1412_CR10","doi-asserted-by":"publisher","first-page":"951185","DOI":"10.3389\/fgene.2022.951185","volume":"13","author":"D Li","year":"2022","unstructured":"Li D, Liang C, Zhang T, Marley JL, Zou W, Lian M, et al. Pathogenic mitochondrial DNA 3243A>G mutation: From genetics to phenotype. Front Genet. 2022;13:951185.","journal-title":"Front Genet"},{"key":"1412_CR11","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ymgme.2016.06.003","volume":"118","author":"V Dvorakova","year":"2016","unstructured":"Dvorakova V, Kolarova H, Magner M, Tesarova M, Hansikova H, Zeman J, et al. The phenotypic spectrum of fifty Czech m.3243A>G carriers. Mol Genet Metab. 2016;118:288\u201395.","journal-title":"Mol Genet Metab"},{"key":"1412_CR12","doi-asserted-by":"publisher","first-page":"e000825","DOI":"10.1136\/bmjno-2024-000825","volume":"6","author":"K Majamaa","year":"2024","unstructured":"Majamaa K, K\u00e4rpp\u00e4 M, Moilanen JS. Neurological manifestations in adult patients with the m.3243A>G variant in mitochondrial DNA. BMJ Neurol Open. 2024;6:e000825.","journal-title":"BMJ Neurol Open"},{"key":"1412_CR13","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.3760\/cma.j.issn.0366-6999.20132799","volume":"127","author":"Y Liu","year":"2014","unstructured":"Liu Y, Xue J, Zhao D, Chen L, Yuan Y, Wang Z. Audiological evaluation in Chinese patients with mitochondrial encephalomyopathies. Chin Med J (Engl). 2014;127:2304\u20139.","journal-title":"Chin Med J (Engl)"},{"key":"1412_CR14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.bbagen.2011.03.015","volume":"1820","author":"S Yatsuga","year":"2012","unstructured":"Yatsuga S, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T, et al. MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta. 2012;1820:619\u201324.","journal-title":"Biochim Biophys Acta"},{"key":"1412_CR15","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1093\/brain\/aww051","volume":"139","author":"PJ Kullar","year":"2016","unstructured":"Kullar PJ, Quail J, Lindsey P, Wilson JA, Horvath R, Yu-Wai-Man P, et al. Both mitochondrial DNA and mitonuclear gene mutations cause hearing loss through cochlear dysfunction. Brain. 2016;139:e33.","journal-title":"Brain"},{"key":"1412_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4158\/EP-2019-0270","volume":"26","author":"KN Robinson","year":"2020","unstructured":"Robinson KN, Terrazas S, Giordano-Mooga S, Xavier NA. The role of Heteroplasmy in the Diagnosis and Management of Maternally Inherited Diabetes and Deafness. Endocr Pr. 2020;26:241\u201346.","journal-title":"Endocr Pr"},{"key":"1412_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5152\/iao.2020.9226","volume":"17","author":"N Zia","year":"2021","unstructured":"Zia N, Nikookam Y, Muzaffar J, Kullar P, Monksfield P, Bance M. Cochlear Implantation Outcomes in Patients with Mitochondrial Hearing Loss: A Systematic Review and Narrative Synthesis. J Int Adv Otol. 2021;17:72\u201380.","journal-title":"J Int Adv Otol"},{"key":"1412_CR18","doi-asserted-by":"crossref","unstructured":"Kanemoto K, Kashio A, Ogata E, Akamatsu Y, Koyama H, Uranaka T, et al. Cochlear Implantation in Patients with Mitochondrial Gene Mutation: Decline in Speech Perception in Retrospective Long-Term Follow-Up Study. Life (Basel). 2022;12:482.","DOI":"10.3390\/life12040482"},{"key":"1412_CR19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/acn3.532","volume":"5","author":"SJ Pickett","year":"2018","unstructured":"Pickett SJ, Grady JP, Ng YS, Gorman GS, Schaefer AM, Wilson IJ, et al. Phenotypic heterogeneity in m.3243A>G mitochondrial disease: The role of nuclear factors. Ann Clin Transl Neurol. 2018;5:333\u201345.","journal-title":"Ann Clin Transl Neurol"},{"key":"1412_CR20","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1212\/01.wnl.0000220197.36849.1e","volume":"66","author":"Y Koga","year":"2006","unstructured":"Koga Y, Akita Y, Junko N, Yatsuga S, Povalko N, Fukiyama R, et al. Endothelial dysfunction in MELAS improved by l-arginine supplementation. Neurology. 2006;66:1766\u20139.","journal-title":"Neurology"},{"key":"1412_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1136\/jnnp-2018-317964","volume":"90","author":"Y Ohsawa","year":"2019","unstructured":"Ohsawa Y, Hagiwara H, Nishimatsu SI, Hirakawa A, Kamimura N, Ohtsubo H, et al. Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial. J Neurol Neurosurg Psychiatry. 2019;90:529\u201336.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01412-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01412-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01412-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T23:02:43Z","timestamp":1772233363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01412-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1412"],"URL":"https:\/\/doi.org\/10.1038\/s10038-025-01412-3","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"27 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}